Serving To Educate Primary Care Clinicians On Metabolic Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Peer-to-peer Exchange Header 3
Metabolic Diseases Header 4
News: Prescriber's Letter March 2015

Metformin used more in patients with kidney disease:

Would loosening restrictions on use of metformin in T2DM increase prescriber's ability to meet the quality measure of decreasing patients with A1C>9% and increasing patients with A1C<8%?

If you would like to access a full sample article from Prescriber's letter articles, please click here

For the most recent full article AND to access all of the benefits of Prescriber's Letter subscribe to an option below:

Prescriber's Letter offers PCMG Members a 10% discount at two subscription levels:

The Gold Subscription is $129 and includes CME

The Platinum Subscription is $189 and provides enhanced CME and Live Webinar access 

Enter Discount Code PCMG15 when ordering either subscription HERE